Your browser doesn't support javascript.
loading
Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma.
Blümel, Edda; Munir Ahmad, Shamaila; Nastasi, Claudia; Willerslev-Olsen, Andreas; Gluud, Maria; Fredholm, Simon; Hu, Tengpeng; Surewaard, Bas G J; Lindahl, Lise M; Fogh, Hanne; Koralov, Sergei B; Rahbek Gjerdrum, Lise Mette; Clark, Rachael A; Iversen, Lars; Krejsgaard, Thorbjørn; Bonefeld, Charlotte Menné; Geisler, Carsten; Becker, Jürgen C; Woetmann, Anders; Andersen, Mads Hald; Buus, Terkild Brink; Ødum, Niels.
Afiliación
  • Blümel E; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Munir Ahmad S; Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev Hospital, Herlev, Denmark.
  • Nastasi C; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Willerslev-Olsen A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Gluud M; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Fredholm S; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Hu T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Surewaard BGJ; Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Canada.
  • Lindahl LM; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Fogh H; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark.
  • Koralov SB; Department of Pathology, New York University School of Medicine, New York, USA.
  • Rahbek Gjerdrum LM; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Clark RA; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Iversen L; Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
  • Krejsgaard T; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Bonefeld CM; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Geisler C; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Becker JC; Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen and Deutsches Krebsforschungszentrum (DKFZ), Essen, Germany.
  • Woetmann A; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Andersen MH; Center for Cancer Immune Therapy (CCIT), Department of Hematology and Oncology, Copenhagen University Hospital, Herlev Hospital, Herlev, Denmark.
  • Buus TB; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Ødum N; LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Oncoimmunology ; 9(1): 1751561, 2020.
Article en En | MEDLINE | ID: mdl-32363124
ABSTRACT
Staphylococcus aureus and its toxins have been linked to disease progression and mortality in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role in anti-cancer responses and high CD8+ T cell numbers in tumor lesions are associated with a favorable prognosis in CTCL. Here, we show that CD8+ T cells from both healthy donors and Sézary syndrome patients are highly susceptible to cell death induced by Staphylococcal alpha-toxin, whereas malignant T cells are not. Importantly, alpha-toxin almost completely blocks cytotoxic killing of CTCL tumor cells by peptide-specific CD8+ T cells, leading to their escape from induced cell death and continued proliferation. These findings suggest that alpha-toxin may favor the persistence of malignant CTCL cells in vivo by inhibiting CD8+ T cell cytotoxicity. Thus, we propose a novel mechanism by which colonization with Staphylococcus aureus may contribute to cancer immune evasion and disease progression in CTCL.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Toxinas Bacterianas / Linfoma Cutáneo de Células T / Linfocitos T CD8-positivos / Proteínas Hemolisinas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2020 Tipo del documento: Article País de afiliación: Dinamarca

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Toxinas Bacterianas / Linfoma Cutáneo de Células T / Linfocitos T CD8-positivos / Proteínas Hemolisinas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncoimmunology Año: 2020 Tipo del documento: Article País de afiliación: Dinamarca